Menu
YourVaccx™* is a breakthrough therapy for metastatic solid tumor cancers that empowers the immune system to attack metastatic cancer throughout the body.
| Matterid | Title | Filed | Mail Date | Appln | Publ. Date | Publ. No. | Issue | Patent No. | Country | Inventors | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 47296-0003002 | IMMUNOLOGIC TREATMENT OF CANCER | 10/9/2019 | 10/09/2019 | 16/597,230 | 2/6/2020 | US-2020-0040095-A1 | 11/15/2022 | 11,497,544 | UNITED STATES | Gary Onik, James A. Miessau, DG Bostwick | ISSUED |
| 47296-0003003 | IMMUNOLOGIC TREATMENT OF CANCER | 3/27/2023 | 03/27/2023 | 18/190,425 | UNITED STATES | Gary Onik, DG Bostwick, James A. Miessau | PENDING | ||||
| 47296-0003CA1 | IMMUNOLOGIC TREATMENT OF CANCER | 1/13/2017 | 07/12/2018 | 3,011,460 | CANADA | Gary Onik, Jim Miessau, DG Bostwick MD, MBA | PENDING | ||||
| 47296-0003CN1 | IMMUNOLOGIC TREATMENT OF CANCER | 1/13/2017 | 07/12/2018 | 201780012169.0 | 12/21/2018 | CN 109069624A | CHINA | Gary Onik, DG Bostwick, James A. Miessau | PENDING | ||
| 47296-0003EP1 | IMMUNOLOGIC TREATMENT OF CANCER | 1/13/2017 | 07/12/2018 | 17739066.3 | 11/21/2018 | 3402517 | EUROPEAN PATENT CONVENTION | Gary Onik, Jim Miessau, DG Bostwick MD, MBA | PUBLISHED | ||
| 47296-0003HK1 | IMMUNOLOGIC TREATMENT OF CANCER | 1/13/2017 | 05/16/2019 | 19124017.5 | 2/14/2020 | 40000716A | HONG KONG | Gary Onik, DG Bostwick, James A. Miessau | PUBLISHED | ||
| 47296-0003JP1 | IMMUNOLOGIC TREATMENT OF CANCER | 1/13/2017 | 07/12/2018 | 2018-555838 | 2/7/2019 | 2019-503398 | JAPAN | Gary Onik, DG Bostwick, James A. Miessau | PUBLISHED | ||
| 47296-0003JP2 | IMMUNOLOGIC TREATMENT OF CANCER | 1/13/2017 | 03/15/2023 | 2023-050754 | 6/27/2023 | 2023-089015 | JAPAN | Gary Onik, DG Bostwick, James A. Miessau | PUBLISHED | ||
| 47296-0003TW1 | IMMUNOLOGIC TREATMENT OF CANCER | 01/11/2017 | 106101466 | 10/16/2017 | 201735951 | TAIWAN | Gary Onik, Jim Miessau, David Bostwick | ALLOWED | |||
| 47296-0003US1 | IMMUNOLOGIC TREATMENT OF CANCER | 7/13/2018 | 07/13/2018 | 16/070,072 | 1/24/2019 | US-2019-0023804-A1 | 3/28/2023 | 11,612,426 | UNITED STATES | Gary Onik, DG Bostwick, James A. Miessau | ISSUED |
| 47296-0005001 | SYSTEM AND METHOD FOR CREATING RADIO-FREQUENCY ENERGY ELECTRICAL MEMBRANE BREAKDOWN FOR TISSUE ABLATION | 8/4/2014 | 08/04/2014 | 14/451,333 | 6/4/2015 | US 2015-0150618 A1 | 12/18/2018 | 10,154,869 | UNITED STATES | Gary M. Onik, James A. Miessau | ISSUED |
| 47296-0005002 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 10/9/2019 | 10/09/2019 | 16/597,249 | 2/6/2020 | US-2020-0038093-A1 | 7/11/2023 | 11,696,797 | UNITED STATES | Gary Onik | ISSUED |
| 47296-0005003/td> | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 11/23/2020 | 11/23/2020 | 17/101,434 | 6/17/2021 | US-2021-0177491-A1 | UNITED STATES | Gary M. Onik, James A. Miessau | PUBLISHED | ||
| 47296-0005AU1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 2014360318 | 10/31/2019 | 2014360318 | 2/13/2020 | 2014360318 | AUSTRALIA | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005AU2 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 01/06/2020 | 2020200688 | 10/14/2021 | 2020200688 | AUSTRALIA | Gary M. Onik, James A. Miessau | ISSUED | ||
| 47296-0005CA1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 2932765 | 6/11/2015 | 2932765 | CANADA | Gary M. Onik, James A. Miessau | PUBLISHED | |||
| 47296-0005CN1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 201480066688.1 | 7/20/2016 | 105792883 | 11/5/2019 | ZL201480066688.1 | CHINA | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005EP1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 14868104.2 | 10/12/2016 | 3077041 | EUROPEAN PATENT CONVENTION | Gary M. Onik, James A. Miessau | PUBLISHED | |||
| 47296-0005HK1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 16110498.8 | 6/30/2017 | 1222360 | 12/24/2020 | HK1222360 | HONG KONG | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005IL1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 245957 | 7/31/2016 | 245957 | 7/2/2022 | 245957 | ISRAEL | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005IN1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 201617021245 | 7/22/2016 | 36/2016 | 12/11/2023 | 480096 | INDIA | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005JP1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN | 12/5/2014 | 2016-536858 | 12/15/2016 | 2016-538961 | 6/25/2020 | 6723153 | JAPAN | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005KR1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 10-2016-7017992 | 8/10/2016 | 10-2016-0095080 | 10/23/2020 | 10-2171496 | SOUTH KOREA | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005MX1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | MX/a/2016/007411 | 2/13/2017 | MX/a/2016/007411 | 2/28/2022 | 390311 | MEXICO | Gary M. Onik, James A. Miessau | ISSUED | |
| 47296-0005MX2 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 12/5/2014 | 02/23/2022 | MX/a/2022/002416 | 5/25/2022 | MEXICO | Gary M. Onik, James A. Miessau | PUBLISHED | |||
| 47296-0005US1 | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) | 6/6/2016 | 06/06/2016 | 15/102,120 | 12/22/2016 | US-2016-0367310-A1 | 12/1/2020 | 10,849,678 | UNITED STATES | Gary M. Onik, James A. Miessau | ISSUED |
| 47296-0006002 | RADIO-FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF HIGH RISK AND RECURRENT PROSTATE CANCER, UNRESECTABLE PANCREATIC CANCER, TUMORS OF THE BREAST, MELANOMA OR OTHER SKIN MALIGNANCIES, SARCOMA, SOFT TISSUE TUMORS, DUCTAL CARCINOMA, NEOPLASIA, AND INTRA AND EXTRA LUMINAL ABNORMAL TISSUE | 9/30/2021 | 09/30/2021 | 17/490,161 | 8/25/2022 | US-2022-0265343-A1 | UNITED STATES | Gary M. Onik, James A. Miessau, David G. Bostwick | PUBLISHED | ||
| 47296-0006EP1 | RADIO FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF TISSUES | 2/1/2016 | 16744266.4 | 12/6/2017 | 3250142 | EUROPEAN PATENT CONVENTION | Gary Onik, James A. Miessau, David G. Bostwick | PUBLISHED | |||
| 47296-0006IN1 | RADIO FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF TISSUES | 2/1/2016 | 201717028687 | 11/10/2017 | 45/2017 | 12/21/2023 | 486891 | INDIA | Gary Onik, James A. Miessau, David G. Bostwick | ISSUED | |
| 47296-0006JP1 | RADIO FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF TISSUES | 2/1/2016 | 2017-540247 | 4/19/2018 | 2018-510677 | 6/25/2020 | 6723249 | JAPAN | Gary Onik, James A. Miessau, David G. Bostwick | ISSUED | |
| 47296-0006KR1 | RADIO FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF TISSUES | 2/1/2016 | 10-2017-7024102 | 10-2017-0125332 | 6/25/2020 | 10-2128856 | SOUTH KOREA | Gary Onik, James A. Miessau, David G. Bostwick | ISSUED | ||
| 47296-0006US1 | RADIO-FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF HIGH RISK AND RECURRENT PROSTATE CANCER, UNRESECTABLE PANCREATIC CANCER, TUMORS OF THE BREAST, MELANOMA OR OTHER SKIN MALIGNANCIES, SARCOMA, SOFT TISSUE TUMORS, DUCTAL CARCINOMA, NEOPLASIA, AND INTRA AND EXTRA LUMINAL ABNORMAL TISSUE | 7/31/2017 | 07/31/2017 | 15/547,631 | 9/20/2018 | US 2018-0263685 A1 | 10/12/2021 | 11,141,216 | UNITED STATES | Gary M. Onik, James A. Miessau, David G. Bostwick | ISSUED |
